Medicine
 |
|
11 december 2019 16:03:12 |
| Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice (Gene Therapy) |
|
Tweet |
| 311 viewsCategory: Genetics, Medicine |
 MicroRNA-204 silencing relieves pain of cervical spondylotic radiculopathy by targeting GDNF (Gene Therapy)Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6 (Gene Therapy) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
